C/EBPα and C/EBPβ Are Required for Sebocyte Differentiation and Stratified Squamous Differentiation in Adult Mouse Skin by House, John S. et al.
C/EBPa and C/EBPb Are Required for Sebocyte
Differentiation and Stratified Squamous Differentiation
in Adult Mouse Skin
John S. House
1, Songyun Zhu
1, Rakesh Ranjan
1, Keith Linder
2, Robert C. Smart
1*
1Cell Signaling and Cancer Group, Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina, United States of
America, 2Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of
America
Abstract
C/EBPa and C/EBPb are bZIP transcription factors that are highly expressed in the interfollicular epidermis and sebaceous
glands of skin and yet germ line deletion of either family member alone has only mild or no effect on keratinocyte biology
and their role in sebocyte biology has never been examined. To address possible functional redundancies and reveal
functional roles of C/EBPa and C/EBPb in postnatal skin, mouse models were developed in which either family member
could be acutely ablated alone or together in the epidermis and sebaceous glands of adult mice. Acute removal of either C/
EBPa or C/EBPb alone in adult mouse skin revealed modest to no discernable changes in epidermis or sebaceous glands. In
contrast, co-ablation of C/EBPa and C/EBPb in postnatal epidermis resulted in disruption of stratified squamous
differentiation characterized by hyperproliferation of basal and suprabasal keratinocytes and a defective basal to spinous
keratinocyte transition involving an expanded basal compartment and a diminished and delayed spinous compartment.
Acute co-ablation of C/EBPa and C/EBPb in sebaceous glands resulted in severe morphological defects, and sebocyte
differentiation was blocked as determined by lack of sebum production and reduced expression of stearoyl-CoA desaturase
(SCD3) and melanocortin 5 receptor (MC5R), two markers of terminal sebocyte differentiation. Specialized sebocytes of
Meibomian glands and preputial glands were also affected. Our results indicate that in adult mouse skin, C/EBPa and C/
EBPb are critically involved in regulating sebocyte differentiation and epidermal homeostasis involving the basal to spinous
keratinocyte transition and basal cell cycle withdrawal.
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Introduction
There are six members of the CCAAT/enhancer binding
protein (C/EBP) family: C/EBPa, C/EBPb, C/EBPc, C/EBPd,
C/EBPe and C/EBPf. C/EBPs are members of the basic leucine
zipper (bZIP) class of transcription factors. C/EBPs play important
roles in fundamental cellular processes including proliferation,
apoptosis, differentiation, inflammation, senescence and energy
metabolism [1,2]. In terms of differentiation, C/EBPa plays a role
in the differentiation of myeloid cells [3,4], alveolar type II cells
[5], hepatocytes [6,7] and adipocytes [8–10] while C/EBPb has a
role in the differentiation process in mammary epithelial cells
[11,12], adipocytes [13], ovarian granulosa cells [14], and
macrophages [15,16].
The interfollicular epidermis (IFE) of skin is a stratified
squamous epithelium composed primarily of keratinocytes that
undergo a highly coordinated program of sequential changes in
gene expression as they migrate from the proliferating basal
keratinocyte layer through morphologically distinct spinous and
then granular suprabasal keratinocyte layers, ending in the
production of a nonviable stratum corneum. A discrete population
of IFE stem cells replenishes the basal cell compartment in the
epidermis[17]. Epidermal homeostasis involves the intricate
regulation and balance between proliferation of basal cells and
their commitment to terminally differentiate. Notch signaling [18–
20] and AP-2a/AP-2c [21] have essential roles in epidermal
development and postnatal epidermal differentiation.
C/EBPa and C/EBPb have been shown to be highly expressed
in mouse and human epidermis [22–24] suggesting a possible role
for these transcription factors in stratified squamous differentia-
tion. However, the analysis of an epidermal specific germline C/
EBPa knockout mouse revealed that C/EBPa is completely
dispensable for epidermal homeostasis involving squamous
differentiation and keratinocyte proliferation [25] and the analysis
of germline C/EBPb knockout mouse epidermis revealed changes,
albeit modest, in keratinocyte differentiation involving decreased
K1 and K10 expression and increased basal keratinocytes
proliferation, indicating a role for C/EBPb in the early events of
stratified differentiation [26]. Because these changes in C/EBPb
deficient epidermis were modest it led to the notion that C/EBPb
has supportive rather than a major role in epidermal keratinocyte
differentiation. However, another possibility for the lack of a major
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that functional redundancies between the transcription factors
mask their roles in the single knockouts. In support of this notion
are studies demonstrating that the knockin of C/EBPb into the C/
EBPa locus can rescue C/EBPa
2/2 mice from perinatal lethality
[27] and restore granulocytic differentiation and glycogen
metabolism [27]. A recent study in developing mouse skin in
which C/EBPa and C/EBPb were co-deleted during epidermal
development produced mice that were only viable for a few hours
after birth, and the analysis of epidermis from these mice revealed
hyperplasia and decreased expression of spinous and granular
markers of differentiation [28]. Thus, while C/EBPa and C/EBPb
are critical for epidermal development, their roles in stratified
squamous differentiation in the adult epidermis remain poorly
understood.
Sebaceous glands extend off of the upper hair follicle and are
formed from a sebocyte progenitor that expresses Blimp 1, keratin
14 (K14) and keratin 5 (K5) [29] and these cells produce a
proliferative population of sebocytes which in turn differentiate to
produce the lipid/sebum producing cells [30]. These differentiated
sebocytes lyse and release their contents of lipids/sebum into the
hair follicle canal and make their way to surface of the skin where
they prevent drying of the skin and hair [31]. cMyc [30,32],
hedgehog signaling [33] and AP-2a/AP-2c [21] regulate seba-
ceous gland development/differentiation. C/EBPa and C/EBPb
are abundantly expressed in sebocytes of the sebaceous glands
[34,35], however, no function for these transcription factors in
sebocytes has been described and no sebaceous gland phenotype
was reported in C/EBPa or C/EBPb knockout mice.
To address possible functional redundancies and to reveal the
functional roles of C/EBPa and C/EBPb in the adult epidermis
and sebaceous gland, mouse models were developed in which
either family member could be ablated alone or together in the
epidermis and sebaceous glands of adult mice. Our results
demonstrate C/EBPa and C/EBPb are essential for sebocyte
differentiation and epidermal squamous differentiation involving
the basal to spinous transition.
Methods
Ethics statement
All animal work described in the study involving animal
husbandry, experimentation, and care/welfare have been con-
ducted according to NIH guidelines and approved by NCSU
Institutional IACUC committee.
Animals and treatments
K14-CreER
tam homozygous mice [36] (CD1) were obtained
from Jackson Labs (#005107) and crossed with either floxed-a
(B6.129)[37], floxed-b (B6.129)[38] or floxed-ab (B6.129). Floxed-
a and floxed-b mice were genotyped as previously described
[37,38]. Mice were genotyped for K14-CreER
tam using the
following primers: forward, CGATGCAACGAGTGATGAG-
GTTC; reverse, GCACGTTCACCGGCATCAAC. Mice 6–8
weeks of age in telogen were treated topically to clipped skin with
4OHT (Sigma catalog # T176-50MG) 1.0 mg/day for days 1–5
and again on days 13–17 dissolved in 95% ethanol (1.0 mg/
200 ul) and skin collected for IHC on day 21.
Preparation of epidermal homogenates
Mice were killed by cervical dislocation and dorsal skin was
removed and subjected to 15 seconds heat shock in 65uC
deionized water followed by 15 seconds in ice water. Water was
removed from skin by blotting between paper towels and
epidermis was scraped from dermis. For C/EBPa and C/EBPb
proteins, epidermal scrapes were homogenized on ice in RIPA
buffer (1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS,
1.5 mM sodium orthovanadate, 1.5 mM phenylmethylsufonyl
fluoride, 1.5 mM dithiothreitol, and 1x protease inhibitor cocktail
(Roche Diagnostics GmbH ref 11 836 001) in PBS), and
centrifugated at 14,000 g for 20 minutes at 4uC. Supernatants
were stored at 280uC prior to use. Protein quantification was
determined by Bio-Rad Protein Assay reagent (Bio-Rad, Cat#
500–0006). For keratins and cornified envelope precursors,
epidermal scrapes were homogenized in 20% 2-mercaptoethanol
and 5% SDS, boiled 5 minutes, allowed to cool and centrifugated
at 14,000 g for 10 minutes.
Immunoblot analysis
Equal amounts of protein were denatured in sample buffer,
loaded onto 12% tris-glycine gels (Invitrogen, EC6005), separated
by gel electrophoresis and transferred to PVDF membrane.
Membranes were blocked for one hour (PBS with 0.1% tween/
5.0% milk/1.0% BSA), and incubated overnight at 4uC (PBS with
0.1% tween/1.0% BSA) with one of the following rabbit
polyclonal antibodies: C/EBPa (Santa Cruz, SC-61, 1:2000), C/
EBPb (Santa Cruz, SC-150, 1:2000), K1 (Covance, 1:10,000), K5
(Covance, 1:10,000), K10 (Covance, 1:10,000), K14 (Covance,
1:10,000), involucrin (Covance, 1:10,000), loricrin (Covance,
1:10,000), filaggrin (Covance, 1:10,000). Membranes were then
rinsed one hour in PBS-T (0.1% tween) and subjected to one hour
incubation (PBS-T, 1.0% BSA) with anti-rabbit IgG, horseradish
peroxidase-linked secondary (GE Healthcare, NA934V, 1:2500),
incubated one minute with Western Lightening Plus-ECL
(PerkinElmer NEL105001EA) and subsequently exposed to film.
Each blot represents n$3 mice per genotype. Membranes were
stripped and re-probed for b-actin (Sigma A-5441, 1:25,000,
mouse) for one hour followed by one hour incubation anti-mouse
horseradish peroxidase-linked secondary (GE Healthcare,
NXA931, 1:25,000), incubated one minute with Western Light-
ening Plus-ECL (PerkinElmer NEL105001EA) and subsequently
exposed to film.
Cell proliferation analysis
Mice were injected intraperitoneally with bromodeoxyuridine
(BrdU, Sigma B5002, 100 mg/kg in PBS) and killed 1 hour later.
Skin was fixed in 10% neutral buffered formalin phosphate (NBF)
for 20 h and moved to 70% ethanol and subsequently embedded
in paraffin. Immunohistochemical (IHC) staining for BrdU was
performed as previously described [23] on 5 mM sections with
anti-BrdU (BD Biosciences 27644, 1:25).
Immunohistochemical (IHC) staining
Tissues were fixed in 10% NBF for 20 h, switched to 70%
ethanol and embedded in paraffin. Tissue sections (5 mM) were
stained for H&E or specific IHC as described [23,26,39] with the
following antibodies: C/EBPa (Santa-Cruz SC-61, 1:1000), C/
EBPb (Santa-Cruz SC-7962, 1:1000), K5 (Covance PRB-160P,
1:2000), K10 (Covance PRB-159P, 1:2000), involucrin (Covance
PRB-140C, 1:2000), loricrin (Covance PRB-145P, 1:2000), K6
(Covance PRB-169P, 1:2000) and fatty acid synthase (FAS-
N)(Santa-Cruz SC-20140, 1:1000).
Oil Red O staining
Fresh unfixed epidermis sections were frozen on liquid nitrogen
in Tissue-TekH O.C.T (Sakura Finetek, #4583) compound and
stored at 280uC. Frozen sections (10 microns) were washed
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isopropanol. Slides were then incubated in Oil Red O for 15
minutes and subsequently washed in 60% isopropanol, 30%
isopropanol, and water. Slides were counterstained with hema-
toxylin, rinsed in water for 10 minutes and coverslipped with
glycerin jelly.
Co-immunofluorescence staining
Tissue slides were deparaffinized and hydrated in successive
washes(Xylene,95%ethanol,70% ethanol, PBS), blocked (K5,K10:
1 h with 1.5% natural goat serum (NGS), 1.5% natural horse serum
(NHS), 1% bovineserum albumin(BSA) inPBS.C/EBPa,C/EBPb:
2 h with 6%NGS, 6%NHS, 1%TritonX in PBS), and incubated
overnight at 4uC with primary antibodies: K5 (rabbit polyclonal,
Covance, 1:1000), K10 (mouse monoclonal, Covance, 1:1000), C/
EBPa (rabbit polyclonal, Santa-Cruz SC-61, 1:400), and C/EBPb
(mouse monoclonal, Santa-Cruz SC-7962, 1:200). Slides were
washed in PBS and incubated 45 minutes with fluorophore-linked
secondary antibodies (Alexa FluorH 568 goat anti-mouse (1:1000),
Alexa FluorH 488 goat anti-rabbit (1:1000)) in PBS, dehydrated and
coverslipped with Dako Faramount Aqueous Mounting Medium.
RNA and quantitative PCR
In brief, mice were killed by cervical dislocation and skin
removed. Whole skin was minced in Sigma Tri-ReagentH,T -
2494, sonicated on ice 4610 s, centrifuged 14,000 g/10 m/4uC,
and RNA was extracted with chloroform. Pelleted RNA was
solubilized in water and then purified with DNase on Qiagen
RNeasyH columns. cDNA was created with equal amounts of
starting template with reverse transcriptase with appropriate no-
RT controls. cDNA was then subjected to Real Time TaqManH
PCR (Applied Biosystems: keratin 10 (Mm03009921_m1), SCD3
(Mm00470480_m1), MC5R (Mm00442970_m1)) using GAPDH
(Mm99999915_g1) as a housekeeping gene) and semi-quantitative
PCR (all others) using the primers given in Table S1. For semi-
quantitative PCR, PCR product was then run on 2% agarose gels
with .01% ethidium bromide. After confirming PCR amplification
was in the linear range by varying the amount of starting template,
optical density of bands were determined by ImageJ
TM. Each
experiment included 3 or more animals of each genotype.
Results
C/EBPa and C/EBPb are co-expressed in skin
The bZIP transcription factors, C/EBPa and C/EBPb are
expressed in mouse epidermis and sebaceous glands [23,24,34].
To determine whether C/EBPa and C/EBPb are co-expressed
within the same cell and not just within the same tissue or gland we
performed co-immunofluorescence labeling for C/EBPa and C/
EBPb in untreated animals. As shown in Fig. 1A, C/EBPa and C/
EBPb are co-expressed in the nuclei of many interfollicular
epidermal (IFE) keratinocytes. Most IFE suprabasal and basal
keratinocytes that expressed C/EBPb also expressed C/EBPa.
However, some basal keratinocytes predominately expressed C/
EBPa. The majority of outer root sheath (ORS) follicular
keratinocytes co-expressed C/EBPa and C/EBPb in their nuclei
as did the vast majority of sebocytes of the sebaceous gland which
displayed the highest levels of staining intensity for C/EBPa and
C/EBPb (Fig. 1B).
Figure 1. C/EBPa/b are co-expressed in skin and acute ablation C/EBPb does not produce a major skin phenotype. Co-IF staining of
untreated mouse skin in: (A) interfollicular epidermis (IFE), and (B) the hair follicle outer root sheath (HF-ORS) and sebaceous gland (SG). (C)
Immunoblot analysis of epidermal lysates from untreated and 4OHT-treated C/EBPb
ff and IKOb mice (n=3 mice/genotype/treatment). (D) IHC
staining for C/EBPb in 4OHT-treated C/EBPb
ff and 4OHT-treated IKOb mouse skin. (E) H&E staining of 4OHT-treated C/EBPb
ff and 4OHT-treated IKOb
mouse skin. (F) Quantification of nucleated cell layers in 4OHT-treated C/EBPb
ff and IKOb mice (n=3 mice/genotype/treatment). (G) Quantification of
basal BrdU positive cells in 4OHT-treated C/EBPb
ff and IKOb mice (n=3 mice/genotype/treatment). (H) IHC staining for BrdU and markers of
squamous differentiation. All scale bars represent 30 microns. *indicates significantly different from controls p,.05, Student’s t test.
doi:10.1371/journal.pone.0009837.g001
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mouse skin does not produce a major skin phenotype
To ablate C/EBPa and C/EBPb in postnatal adult mouse skin
we used a conditional inducible approach utilizing K14-CreER
tam
mice [36]. The K14 promoter directs the expression CreER
tam to
the basal layer of the epidermis, ORS follicular keratinocytes of
the hair follicle as well as the progenitor and proliferative
populations of sebocytes of the sebaceous gland of mouse skin.
The activity of CreER
tam is regulated through topical treatment
with the synthetic ER antagonist, 4-hydroxytamoxifen (4OHT).
While the overall goal was to simultaneously acutely ablate C/
EBPa and C/EBPb in adult mouse skin, it was first necessary to
characterize the epidermis of adult mice in which C/EBPa or C/
EBPb were individually acutely ablated. While the phenotypes of
the epidermal specific germline knockouts of C/EBPa and C/
EBPb have been previously characterized [25,26], it could not be
assumed that acute ablation in fully-developed adult skin would
mimic the germline embryonic knockouts where developmental
compensatory events could have occurred in the embryo to mask a
postnatal phenotype. Moreover, in order to accurately define and
interpret the phenotype of the double knockout it was important to
determine the phenotype of single C/EBP knockouts in the same
experimental model system.
K14-CreER
tam;C/EBPa
ff mice and K14-CreER
tam;C/EBPb
ff
mice were generated and we first analyzed K14-CreER
tam;C/
EBPb
ff mice (hereafter referred to as (inducible knock out) IKOb
mice). Before treating mice with 4OHT, the levels of C/EBPb
protein in the epidermal homogenates of untreated IKOb and
untreated C/EBPb
ff mice (b
ff) were examined. Immunoblot
analysis demonstrated epidermal C/EBPb levels were similar in
the two genotypes indicating the CreER
tam fusion protein was not
significantly active in the absence of 4OHT treatment (Fig. 1C).
4OHT treatment (1.0 mg 4OHT/day for days 1–5 and 13–17;
skin was collected on day 21), had no significant effect on C/EBPa
or C/EBPb levels in floxed-b mice (Fig. 1C), however, 4OHT
treatment resulted in near complete ablation of C/EBPb in IKOb
epidermis and this was consistently accompanied by a modest
increase in C/EBPa levels suggesting possible compensatory
upregulation (Fig. 1C). C/EBPb is expressed in three forms
(LAP* (39 kD), LAP (36 kD) and LIP (20 kDa) due to the use of
alternative translation initiation sites and all forms of C/EBPb
were decreased in 4OHT-treated IKOb mice (data not shown).
Immunohistochemical (IHC) staining for C/EBPb confirmed the
loss of C/EBPb in the IFE and revealed the loss of C/EBPb in the
ORS follicular keratinocytes of the hair follicle and sebocytes of
sebaceous gland (Fig. 1D). The 4OHT-treated IKOb epidermis
displayed a moderate increase in: epidermal thickness (Fig. 1E
right), the number of nucleated cell layers (Fig. 1F) and the
number of BrdU positive basal keratinocytes following a 1 hour
pulse was increased (Fig. 1G first panel). Overall, with the
exception of the epidermal thickness and the increase in nucleated
cell layers, the morphology of the IFE, ORS of the hair follicle and
sebaceous glands of the 4OHT-treated IKOb epidermis were
indistinguishable from 4OHT-treated b
ff mice (Fig. 1E). IHC
staining for K5, K10, loricrin and involucrin in C/EBPb
ff and
IKOb epidermis treated with 4OHT revealed the correct spatial
expression patterns, however, similar to germline C/EBPb
knockout mice [26], we observed a modest decreased staining
intensity for K10 (Fig. 1H).
Next, K14-CreER
tam;C/EBPa
ff (IKOa) were examined. Base-
line levels of C/EBPa protein in the epidermis of untreated IKOa
mice and control C/EBPa
ff (a
ff) mice were similar and the topical
application of 4OHT to IKOa mice resulted in greatly reduced
levels of C/EBPa and a modest increase in C/EBPb (Fig. 2A).
Both isoforms of C/EBPa ((p42 (42 kD) and p30 (30 kD)) were
similarly decreased after treatment with 4OHT (data not shown).
IHC staining for C/EBPa demonstrated the loss of C/EBPa in the
IFE, ORS cells of the hair follicle and sebocytes in 4OHT treated
IKOa animals (Fig. 2B). Epidermal thickness and basal cell
proliferation as measured by BrdU incorporation was moderately
increased in 4OHT-treated IKOa vs. 4OHT-treated C/EBPa
ff
(Fig. 2D). With the exception of a slight increase epidermal
thickness proliferation, the morphology of the IFE, ORS follicular
epidermis and sebaceous glands of the 4OHT-treated IKOa
epidermis were indistinguishable from 4OHT-treated C/EBPa
ff
mice (Fig. 2C) as was the IHC staining for K5, K10, loricrin and
involucrin in epidermis (data not shown). In summary, with the
exception of modest increases in epidermal proliferation in
4OHT-treated IKOa mice, the acute single ablation of C/EBPa
or C/EBPb in adult mouse epidermis results in a phenotype
similar to the germline knockout phenotype [25,26], indicating
developmental compensatory events do not have a major role in
masking the postnatal germline knockout phenotype.
Figure 2. Acute ablation C/EBPa does not produce a major skin
phenotype. (A) Immunoblot analysis of epidermal lysates from
untreated and 4OHT-treated C/EBPa
ff and IKOa mice (n=3 mice/
genotype/treatment). (B) IHC staining for C/EBPa in 4OHT-treated C/
EBPa
ff and 4OHT-treated IKOa mouse skin. (C) H&E staining of 4OHT-
treated C/EBPa
ff and 4OHT-treated IKOa mouse skin. (D) Quantification
of nucleated cell layers and number of basal BrdU positive cells in
4OHT-treated C/EBPa
ff and IKOa mice (n=3 mice/genotype/treatment).
All scale bars represent 30 microns. *indicates significantly different
from controls p,.05, Student’s t test.
doi:10.1371/journal.pone.0009837.g002
Roles of C/EBPs in Adult Skin
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9837Acute co-ablation of C/EBPa and C/EBPb results in severe
morphological defects in epidermis involving
hyperplasia, dysplasia and hyperkeratosis
To address potential functional redundancies between C/EBPa
and C/EBPb and unmask their function in epidermis and
sebaceous glands, K14-CreER
tam;C/EBPa
ff;C/EBPb
ff (IKOab)
and C/EBPa
ff;C/EBPb
ff (a
ffb
ff) mice were generated and
characterized. Immunoblot analysis demonstrated the levels of
C/EBPa and C/EBPb in the untreated epidermis of IKOab mice
and a
ffb
ff mice were similar (Fig. 3A), and the topical application
of 4OHT to IKOab and a
ffb
ff mice resulted in dramatic decreases
in both C/EBPa and C/EBPb in IKOab but not 4OHT-treated
a
ffb
ff mice (Fig. 3A). All forms of C/EBPb (LAP*, LAP and LIP)
and C/EBPa (p42 and p30) were similarly decreased (data not
shown). Loss of C/EBPa and C/EBPb in the IFE, ORS follicular
keratinocytes and sebocytes was demonstrated by co-IF staining
for C/EBPa and C/EBPb in 4OHT-treated IKOab and 4OHT-
treated a
ffb
ff mouse skin (Fig. 3B). In normal IFE, basal
keratinocytes progress upwards through morphologically distinct
spinous and then granular suprabasal layers, eventually ending in
the production of a nonviable stratum corneum or cornified layer.
Histological analysis of dorsal skin sections from 4OHT-treated
IKOab and 4OHT-treated a
ffb
ff mice revealed a
ffb
ff IFE was
normal (Fig. 3D). In contrast, the 4OHT-treated IKOab IFE and
infundibular ORS keratinocytes were hyperplastic (Fig. 3E&F) and
the IFE displayed a significant increase in the number of nucleated
epidermal cell layers (Fig. 3C). In addition, the basal and spinous
layers of the 4OHT-treated IKOab epidermis were dysplastic as
characterized by the disorganization of the layers and by highly
abnormal variations in cell and nucleus size (Fig. 3G&H). There
were also focal and regional areas of moderate to severe
hyperplasia of the follicular infundibular epithelium and ORS
keratinocytes (Fig. 3F) in the 4OHT-treated IKOab epidermis. In
contrast to the disorganized basal and spinous layers, the granular
layer of keratinocytes in 4OHT-treated IKOab mice appeared less
affected and keratohyalin granules, a hallmark of granular layer,
were present at levels similar to 4OHT-treated control mice
(Fig. 3I-J). The stratum corneum in 4OHT-treated IKOab
epidermis was significantly thickened (hyperkeratosis) (Fig. 3E-G)
and displayed low levels of parakeratosis. Collectively, these
morphological and histological alterations in the 4OHT-treated
IKOab epidermis indicate the acute loss of C/EBPa and C/EBPb
disrupts epidermal homeostasis, and within the viable epidermis,
the basal and spinous layers appear to be most severely affected.
We also examined mice at different times after the start of 4OHT
treatment to determine when epidermal abnormalities appeared.
We observed focal areas of hyperplasia in as early as four days
from start of treatment and these areas became more exten-
sive and severe at 8, 12, and 18 days from start of treatment
(Fig. 3K).
Figure 3. Acute co-ablation of C/EBPa/b results in epidermal morphological defects. (A) Immunoblot analysis of epidermal lysates from
untreated and 4OHT-treated a
ffb
ff and IKOab mice (n=3 mice/genotype/treatment). (B) Co-IF staining for C/EBPa and C/EBPb in 4OHT-treated a
ffb
ff
and 4OHT-treated IKOab mouse skin. (C) Quantification of epidermal nucleated cell layers in 4OHT-treated mice. (D) H&E staining of 4OHT-treated
a
ffb
ff mice. (E) H&E staining of 4OHT-treated IKOab mice. (F) Characteristic H&E staining of lesion in 4OHT-treated IKOab mouse. (G) H&E staining of
4OHT-treated IKOab epidermis with (H) region enlarged displaying dysplasia. (I) H&E staining and TEM micrograph of keratohyalin granules in 4OHT-
treated (I) a
ffb
ff and 4OHT-treated (J) IKOab epidermis. (K) H&E staining of lesions from 4OHT-treated animals from different days after start of 4OHT
treatment. Scale bars represent 30 microns unless otherwise notated. *indicates significantly different from controls p,.05, Student’s t test.
doi:10.1371/journal.pone.0009837.g003
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specific molecular defects in squamous differentiation
4OHT-treated IKOab epidermis was analyzed for specific
molecular defects in differentiation using IHC staining for
molecular markers of specific stages of squamous differentiation.
IHC staining in a
ffb
ff and IKOab epidermis from mice treated
with 4OHT were conducted side by side and 3,39-diaminobenzi-
dine (DAB) incubation time was standardized to 4OHT-treated
a
ffb
ff epidermis. In 4OHT-treated IKOab epidermis, the basal
cell markers, K5 and K14, were no longer restricted to the basal
layer, but were aberrantly expressed throughout all suprabasal
layers of the epidermis (Fig. 4A). However, K14 and especially
K5 IHC staining were significantly less intense in 4OHT-treated
IKOab epidermis than in 4OHT-treated a
ffb
ff epidermis.
Immunoblot analysis of epidermal lysates from 4OHT treated
a
ffb
ff and 4OHT-treated IKOab epidermis (Fig. 4B) revealed
increased levels of K14 in IKOab epidermis, while K5 showed
similar levels to a
ffb
ff controls substantiating the IHC results
showing reduced levels but a greatly expanded K5 compartment
(Fig. 4A). K10, an early marker of the spinous layer and of the
basal to spinous transition was significantly reduced in 4OHT-
treated IKOab epidermis (Fig. 4A). K1, another early marker of
the spinous layer was delayed in its expression in 4OHT-treated
IKOab epidermis and instead of being expressed in the layer
adjacent to the basal cell layer, K1 was not expressed until ,2-3
layers of cells above the basal layers (Fig. 4A). Immunoblot
analysis for K1 and K10 confirmed the IHC results (Fig. 4B).
In general, markers of later stages of differentiation such as
involucrin and filaggrin were not decreased. Involucrin, a
component of the cornified envelope and a marker of the
granular layer, was expressed in the appropriate layers but at
higher levels compared to similarly treated a
ffb
ff epidermis
(Fig. 4A-C). Filaggrin, a marker of the granular layer was also
expressed at higher levels in 4OHT-treated IKOab epidermis
than in similarly treated a
ffb
ff epidermis (Fig. 4B). In contrast, the
expression of loricrin, a component of the cornified envelope, was
significantly diminished in 4OHT-treated IKOab epidermis
(Fig. 4A-C). In general, mRNA levels of the various differenti-
ation markers were in accord with immunoblot and IHC levels
(Fig. 4C). Overall the molecular changes in K5, K14, K1, and
K10 in the 4OHT-treated IKOab epidermis are consistent with a
defect in the basal to spinous transition.
Figure 4. Co-ablation of C/EBPa/b results in defects in epidermal squamous differentiation. (A) IHC staining for markers of stratified
squamous differentiation in 4OHT-treated controls and 4OHT-treated inducible double knockouts (IKOab). (B) Immunoblot analysis of epidermal
lysates from animals treated with 4OHT for markers of stratified squamous differentiation (n=3 mice/genotype). (C) TaqmanH real time quantitative
PCR (K10) and reverse transcriptase semi-quantitative PCR (all others) on mRNA from 4OHT-treated whole skin (n=5 mice/genotype). Scale bars
represent 30 microns.
doi:10.1371/journal.pone.0009837.g004
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hyperproliferative basal and suprabasal keratinocytes
Cell proliferation analysis was conducted using a 1 h pulse label
with BrdU, followed by IHC analysis for BrdU positive S-phase
cells. 4OHT-treated IKOab epidermis demonstrated a significant
increase in the numbers of BrdU positive S-phase cells in the IFE
and ORS keratinocytes (Fig. 5 A&B) over 4OHT-treated a
ffb
ff
epidermis. In 4OHT-treated IKOab IFE, there was a 4.7 fold
increase in BrdU positive basal S-phase keratinocytes compared to
similarly treated a
ffb
ff mice (Fig. 5C). In normal epidermis,
suprabasal proliferating keratinocytes are infrequent as proliferat-
ing keratinocytes are restricted to the basal layer. Analysis of
4OHT-treated IKOab epidermis revealed suprabasal BrdU
positive S-phase keratinocytes were greatly increased and were
observed at a ,27 fold increase over 4OHT-treated a
ffb
ff
epidermis (Fig. 5B&C). Collectively, these results demonstrate
hyperproliferative basal and suprabasal keratinocytes and suggest
an impairment of basal keratinocyte cell cycle withdrawal in mice
missing C/EBPa and C/EBPb.
Acute co-ablation of C/EBPa and C/EBPb results in
molecular, morphological and differentiation defects in
sebocytes
In untreated mouse skin, sebaceous glands are associated with
the upper follicle and these glands contained numerous sebocytes
with a large light staining, finely vacuolated, clear translucent
cytoplasm and a distinct round nucleus. Small reserve cells,
(proliferative undifferentiated sebocytes) were less numerous and
were peripheral in the glands (Fig. 6A). In the skin of 4OHT-
treated IKOab mice, hair follicles contained distinct sebaceous
gland lobules in the typical location on the hair follicle (Fig. 6B);
however, these glands contained unusual looking sebocytes that
appeared undifferentiated, had reduced cytoplasmic volume and
lacked clear fine vacuolation supportive of lipid accumulation.
Affected glands had an increased cellular density with more closely
apposed nuclei and the cells were morphologically reminiscent of
the reserve undifferentiated cells. To determine whether other
sebaceous type glands were similarly affected, we examine the
Meibomian and preputial glands for C/EBPa and C/EBPb
Figure 5. Co-ablation of C/EBPa/b results in hyperproliferative basal and suprabasal keratinocytes. (A) IHC staining for BrdU-positive
keratinocytes in HF-ORS and IFE in 4OHT-treated a
ffb
ff and 4OHT-treated IKOab epidermis. (B) Suprabasal BrdU-positive S-phase keratinocytes in
4OHT-treated IKOab mice. (C) Quantification of BrdU-positive basal and suprabasal IFE keratinocytes in 4OHT-treated a
ffb
ff and 4OHT-treated IKOab
mice (n=3 mice/genotype, 3 strips per mouse; *p,0.05). Scale bars represent 30 microns.
doi:10.1371/journal.pone.0009837.g005
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Meibomian glands are found at the rim of the eyelid of mammals
and the Meibomian sebocytes produce and release a sebum-like
substance onto the eye that functions to prevent the evaporation of
the tear film on the eye [40]. The preputial gland, found in some
male mammals and located in the subcutaneous tissue of the
inguinal area, is involved in the production and secretion of
pheromones and lipids. Co-IF staining revealed C/EBPa and C/
EBPb were co-expressed in sebocytes of both the Meibomian and
preputial glands (Fig. 6C&D). Gross examination of 4OHT-
treated IKOab mice revealed that eyes of these mice appeared
dry, swollen, and partially closed. Histological analysis revealed
atrophied Meibomian glands characterized by greatly reduced
lobule size and diminished numbers of differentiated sebocytes
with clear vacuolated cytoplasm (Fig. 6E). In addition, there was
severe regional epidermal hyperplasia of the haired skin eyelid
epidermis as well as hyperplasia of the Meibomian ducts and
follicular infundibula, which was similar to skin epithelium (Fig. 6E
right panel). In contrast, eyes of 4OHT-treated a
ffb
ff mice were
normal and the mice contained normal appearing Meibomian
glands and ducts (Fig. 6E). Preputial glands from 4OHT-treated
IKOab mice were also abnormal. The 4OHT-treated a
ffb
ff mice
displayed preputial glandular cells with typical, abundant, clear,
finely vacuolated, translucent cytoplasm and distinct round nuclei
(Fig. 6F circle). In contrast, 4OHT-treated IKOab mice had
marked atrophy of preputial gland lobules and decreased numbers
of clear finely vacuolated sebocytes (Fig. 6F right). Thus, the acute
lost of C/EBPa and C/EBPb severely impairs sebaceous,
Meibomian, and preputial gland homeostasis and results in the
loss of morphologically distinct differentiated sebocytes in all of
these glands. To provide biochemical evidence for altered sebocyte
differentiation, histological sections of skin of 4OHT-treated a
ffb
ff
and 4OHT-treated IKOab mice were subjected to Oil Red O
staining. Oil Red O stains lipid and sebum and positive Oil Red O
staining of sebaceous glands is a hallmark of sebocyte differenti-
ation. In 4OHT-treated a
ffb
ff mice, Oil Red O stained all
Figure 6. Co-ablation of C/EBPa/b results in morphological and molecular defects in sebaceous, Meibomian and preputial glands.
(A) H&E staining of sebaceous glands/lobules of 4OHT-treated a
ffb
ff and (B) 4OHT-treated IKOab mice. Co-IF staining in (C) Meibomian glands and (D)
preputial glands in untreated controls. H&E staining of (E) Meibomian glands (circled) and (F) preputial glands (circled) of 4OHT-treated a
ffb
ff and
4OHT-treated IKOab mice. (G) Oil Red O staining for lipids in 4OHT-treated a
ffb
ff (arrows point to sebaceous glands) and 4OHT-treated IKOab mice
(arrows point to sebaceous lobules). (H) FASN: Semi-quantitative reverse transcriptase PCR on whole skin mRNA from 4OHT-treated a
ffb
ff and 4OHT-
treated IKOab mice. SCD3 and MC5R: TaqManH Real Time PCR. (n=5 mice/treatment/genotype; *p,0.05). IHC staining for (I) keratin 14 and (J) FASN
in 4OHT-treated a
ffb
ff and 4OHT-treated IKOab mouse epidermis (AD-Adipose Tissue). Scale bars represent 30 microns.
doi:10.1371/journal.pone.0009837.g006
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differentiated sebum producing sebocytes associated with nearly
every hair follicle (Fig. 6G). In contrast, the sebaceous gland
lobules associated with hair follicles in 4OHT-treated IKOab
mice did not stain with Oil Red O (Fig. 6G right and bottom right
panels) indicating the absence of sebum and terminally differen-
tiated sebocytes. To further characterize the sebaceous gland
defect in 4OHT-treated IKOab mice, we examined K14, fatty
acid synthase (FASN), stearoyl-CoA desaturase (SCD3) and
melanocortin 5 receptor (MC5R). K14 is expressed in the basal
IFE keratinocytes and is also expressed in the undifferentiated
peripheral sebocytes in sebaceous glands, while SCD3 and MC5R
have been characterized as specific markers of sebocyte differen-
tiation. Within the sebaceous glands of 4OHT-treated a
ffb
ff mice,
K14 is appropriately expressed in the undifferentiated sebocytes
around the periphery of sebaceous gland (Fig. 6I). In contrast, the
entire 4OHT-treated IKOab sebocyte lobule uniformly expressed
K14 suggesting that the lobule may be composed of a population
of undifferentiated sebocytes. To further identify these cells within
the lobule as sebocytes we conducted IHC staining for FASN.
Sebaceous glands in 4OHT-treated a
ffb
ff mice expressed FASN as
did 4OHT-treated IKOab sebocyte lobules indicating that the
lobules are comprised of sebocytes (Fig. 6J). The intense FASN
staining of 4OHT-treated IKOab sebocyte lobules compared to
control glands is likely due to reduced cytoplasmic volume of
IKOab sebocytes. FASN mRNA levels were similar in skin
between the two genotypes (Fig. 6H). SCD3 and MC5R are
markers of terminally differentiated sebocytes and real time
quantitative PCR revealed mRNA of both were greatly reduced
in 4OHT-treated IKOab. Collectively these morphological,
biochemical and molecular results indicate that acute co-ablation
of C/EBPa and C/EBPb in adult mice results in a significant
sebaceous gland defect in which sebocyte terminal differentiation
and lipid production is impaired.
Discussion
The co-ablation of C/EBPa and C/EBPb in adult mouse skin
revealed critical biological functions for these transcription factors
in keratinocytes and sebocytes that are not present in germ line
single knockout mice [25,26] as well as the inducible conditional
single knockout mice described in this study. For example,
sebaceous glands of C/EBPa or C/EBPb knockout mice were
indistinguishable from wild type sebaceous glands. In contrast, the
co-ablation of C/EBPa and C/EBPb resulted in severe sebaceous
gland morphological defects and a failure of sebocyte differenti-
ation. Likewise, acute co-deletion of C/EBPa and C/EBPb
produces profound changes in epidermal homeostasis not seen in
single KOs that involves the disruption of stratified squamous
differentiation, disorganization of the epidermis and the hyper-
proliferation of the IFE keratinocytes as well as ORS follicular
keratinocytes. Thus the co-ablation of C/EBPa and C/EBPb has
revealed previously unknown functional roles for these transcrip-
tion factors in sebocyte biology and has confirmed and eclipsed
earlier studies in C/EBPb knockout mice that indicated a role for
C/EBPb in early events of keratinocyte differentiation involving
K1/K10 expression and growth arrest [26]. Our results indicate
that functional redundancies exist between C/EBPa and C/EBPb
and/or these two transcription factors cooperate to regulate basal
keratinocyte cell cycle withdrawal and early differentiation in
keratinocytes and sebocytes.
Sebaceous glands are formed from a sebocyte progenitor that
expresses Blimp 1, keratin 14 (K14) and K5 [29], and these cells
produce a proliferative population of sebocytes [30,32] which in
turn differentiate into the lipid/sebum producing cells. Through
the inducible conditional co-ablation of C/EBPa and C/EBPb we
unmasked novel roles for these transcription factors in sebaceous
gland differentiation. Sebocytes lacking C/EBPa and C/EBPb
were morphologically altered and sebum production was blocked.
IKOab mice retained distinct sebaceous gland lobules, but these
cells did not produce sebum, a hallmark of sebocyte differentia-
tion. It appears the proliferating cells located on the periphery of
the gland continued dividing but their progeny were unable to
initiate terminal differentiation. Our observation that the cells in
the lobules of IKOab mice express K14 and FASN is consistent
with this idea, providing compelling evidence that the cells within
the lobule are sebocytes. In addition, we observed decreased levels
of SCD3 and MC5R, two markers of differentiated sebocytes. Our
results indicate the adipogenic transcription factors, C/EBPa and
C/EBPb, also have critical roles in sebocyte differentiation
through the regulation of lipogenesis and sebum production.
The critical importance of these transcription factors in sebocyte
homeostasis was further strengthened by the profound effect of
their co-ablation on the specialized sebocytes of the Meibomian
and preputial glands. Meibomian glands of mice lacking C/EBPa
and C/EBPb were severely disorganized, dysplastic and there was
evidence of bacterial infection. Posterior blepharitus is a human
disease often characterized by improper sebum production by
Meibomian glands, lending an environment favorable for bacterial
growth, and accompanied by inflammation [41]. Acne, seborrheic
dermatitis, blepharitis, and sebaceous cancer are among several
human health conditions involving altered sebocyte homeostasis. It
seems plausible the transcription factors C/EBPa and C/EBPb
could have involvement in these disease conditions.
Molecular analysis of IKOab epidermis revealed that K5 and
K14, markers of basal keratinocytes, were expressed throughout
the basal and suprabasal layers, while suprabasal markers K1 and
K10 were delayed or weakly expressed. A concomitant increase in
hyperproliferative basal and suprabasal IFE keratinocytes was
observed in IKOab epidermis. These results indicate an expansion
of the basal compartment and reduced ability of these basal
keratinocytes to initiate the early events of stratified squamous
differentiation involving K1 and K10 expression and cell cycle
withdrawal. Both C/EBPa and C/EBPb can bind to and activate
the K10 promoter and C/EBP binding sites [42] have been
identified in both the K1 and K10 promoters [26] suggesting
differences in K1 and K10 expression could be regulated directly
by C/EBPs at the promoter level. Chromatin immuno-precipita-
tion experiments will be required to resolve these issues.
In general, the granular layers of IKOab epidermis appeared
less affected; keratohyalin granules were present and involucrin
and filaggrin were expressed, albeit at increased levels. These
changes in increased involucrin and filaggrin expression could be a
response to the disruption of epidermal homeostasis due to the
defective basal to spinous transition or it is possible that C/EBPa
and C/EBPb contribute to the suppression of granular differen-
tiation as has been reported for Hes1 in epidermal development
[19].
Mechanisms of epidermal development and postnatal differen-
tiation are not necessarily synonymous. For example, ablation of
Notch in epidermal development produces the loss of spinous and
granular layers and a hypoproliferative phenotype [18], while
postnatal ablation of Notch1 produce an opposite effect involving
a hyperproliferative phenotype and an increased granular layer
[20]. Hes1 ablation dramatically alters epidermal development
involving the spinous to granular transition, but appears to have a
minimal role in adult skin [19]. Recently the co-deletion of C/
EBPa and C/EBPb in developing mouse skin produced mice that
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revealed hyperplasia, decreased expression of spinous and
granular markers of differentiation and a role for E2F in the
hyperplastic epidermis [28]. While we observed similar changes in
basal cell hyperproliferation and defects in spinous markers of
differentiation, we did not observe the granular changes reported
in developing skin. For example, we did not observe diminished
keratohyalin granules, filaggrin, and involucrin expression in adult
epidermis and we did observe an uncoupling of involucrin and
loricrin expression in adult epidermis. Collectively, these results
indicate that there are significant differences between the effects of
co-deletion of C/EBPa and C/EBPb in embryonic development
and postnatal differentiation.
Notch signaling is important in both the early and later stages of
epidermal development where it regulates the basal to spinous
transition in a Hes1 independent manner and the spinous to
granular transition in a Hes1 dependent manner [18–20]. AP-2a
and AP-2c also have essential roles in both the early and later
stages of epidermal development and recently it was reported that
both AP-2 and Notch signaling converge on the regulation of the
expression of C/EBPa and C/EBPb [21]. Results reported in our
current study demonstrate C/EBPa and C/EBPb have critical
roles in the early stages of squamous differentiation and our results
are consistent with a model where C/EBPs function downstream
of AP-2 and Notch signaling to regulate the basal to spinous
transition.
As described in the introduction, the knockin of C/EBPb into
the C/EBPa locus rescues the lethality of C/EBPa
2/2 mice and
supports the notion of functional redundancies between these
family members [27,43]. However, not all of the phenotypes of C/
EBPa
2/2 mouse were reversed suggesting that there are also
unique C/EBP family member functions. Likewise our current
study provides evidence for functional redundancies between C/
EBPa and C/EBPb in epidermal and sebocyte homeostasis.
However, in terms of skin tumorigenesis, these family members
have unique functions. For example, C/EBPa is a skin tumor
suppressor [25] and a regulator of the G1 checkpoint in
keratinocytes in the DNA damage response [44]. In contrast, C/
EBPb is a mediator of keratinocyte survival and is required for skin
tumorigenesis [45]. Understanding the redundant and unique
roles these two transcription factors have will be important in the
eventual elucidation of their roles in tumorigenesis.
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